Review Note

Last Update: 02/28/2025 09:28 PM

Current Deck: Kyle MS1 MJBS::CVS::Week 3 Pharm pt 2::Sketchy

Published

Fields:

Text

Class III antiarrhythmics (K⁺ channel blockers) exert their effects by prolonging phase {{c1::2}} and {{c1::3}} of the myocardial action potential

Extra

Prolongs the action potential and effective refractory period

Lecture Notes

Missed Questions

Pathoma

Boards and Beyond

First Aid

Sketchy

Watch Class III Antiarrhythmics

Sketchy 2

Sketchy Extra

Picmonic

Pixorize

Watch Dofetilide & Ibutilide

Watch Sotalol

Review Amiodarone

Physeo

Bootcamp

Watch associated Bootcamp video - Antiarrhythmics : Class III Antiarrhythmics

OME

Additional Resources

One by one

ankihub_id

2d9814a4-5275-47ae-a04e-37a958337b9c

Tags:

!AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::0MaeMO

#AK_Step1_v12::#AMBOSS::d0aoUQ #AK_Step1_v12::#AMBOSS::g5aFjO #AK_Step1_v12::#AMBOSS::Nca-cj #AK_Step1_v12::#B&B::05_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs_I #AK_Step1_v12::#B&B::05_Cardio::04_Arrhythmias::07_Antiarrhythmic_Drugs_II #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::04_Class_III_Antiarrhythmics #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::13_Antiarrhythmics-potassium_channel_blockers_(class_III) #AK_Step1_v12::#OME::04_Organ_Systems::01_Cardiology::04_Electricity::05_Anti-Arrhythmics #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::01_Cardiology::04_Electricity::05_Anti-Arrhythmics #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::19_Class_III_Antiarrhythmics #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::11_Class_III_Antiarrhythmics-Amiodarone #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::12_Class_III_Antiarrythmics-Sotalol #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::13_Class_III_Antiarrhythmics-Ibutilide #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::02_Dofetilide_&_Ibutilide #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::07_Class_III_Sotalol #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::08_Class_III_Amiodarone #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::03_Class_III #AK_Step1_v12::#UWorld::COMLEX::24013 #AK_Step1_v12::#UWorld::COMLEX::24618 #AK_Step1_v12::#UWorld::Step::1507 #AK_Step1_v12::#UWorld::Step::901 #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #PANCE::CARDIO::conduction_disorders/dysrhythmias #PANCE::EOR::Family_med #PANCE::EOR::IM

Suggested Changes:

Deck Changes (Suggestion to move the Note to the following Deck):

Field Changes:

Tag Changes: